These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 20944860)
1. A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles. Ai Tran HN; Sousa F; Moda F; Mandal S; Chanana M; Vimercati C; Morbin M; Krol S; Tagliavini F; Legname G Nanoscale; 2010 Dec; 2(12):2724-32. PubMed ID: 20944860 [TBL] [Abstract][Full Text] [Related]
2. Living fungi cells encapsulated in polyelectrolyte shells doped with metal nanoparticles. Fakhrullin RF; Zamaleeva AI; Morozov MV; Tazetdinova DI; Alimova FK; Hilmutdinov AK; Zhdanov RI; Kahraman M; Culha M Langmuir; 2009 Apr; 25(8):4628-34. PubMed ID: 19239251 [TBL] [Abstract][Full Text] [Related]
3. Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study. Sousa F; Mandal S; Garrovo C; Astolfo A; Bonifacio A; Latawiec D; Menk RH; Arfelli F; Huewel S; Legname G; Galla HJ; Krol S Nanoscale; 2010 Dec; 2(12):2826-34. PubMed ID: 20949211 [TBL] [Abstract][Full Text] [Related]
4. Multilayer coating of gold nanoparticles with drug-polymer coadsorbates. Reum N; Fink-Straube C; Klein T; Hartmann RW; Lehr CM; Schneider M Langmuir; 2010 Nov; 26(22):16901-8. PubMed ID: 20964349 [TBL] [Abstract][Full Text] [Related]
5. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication. Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680 [TBL] [Abstract][Full Text] [Related]
7. The effect of Fenton reaction on protease-resistant prion protein (PrPSc) degradation and scrapie infectivity. Park SJ; Kim NH; Jeong BH; Jin JK; Choi JK; Park YJ; Kim JI; Carp RI; Kim YS Brain Res; 2008 Oct; 1238():172-80. PubMed ID: 18771660 [TBL] [Abstract][Full Text] [Related]
8. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Khlebtsov N; Dykman L Chem Soc Rev; 2011 Mar; 40(3):1647-71. PubMed ID: 21082078 [TBL] [Abstract][Full Text] [Related]
9. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175 [TBL] [Abstract][Full Text] [Related]
10. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329 [TBL] [Abstract][Full Text] [Related]
11. Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. Iwamaru Y; Takenouchi T; Ogihara K; Hoshino M; Takata M; Imamura M; Tagawa Y; Hayashi-Kato H; Ushiki-Kaku Y; Shimizu Y; Okada H; Shinagawa M; Kitani H; Yokoyama T J Virol; 2007 Feb; 81(3):1524-7. PubMed ID: 17121794 [TBL] [Abstract][Full Text] [Related]
12. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin. Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796 [TBL] [Abstract][Full Text] [Related]
13. Stoichiometric functionalization of gold nanoparticles in solution through a free radical polymerization approach. Krüger C; Agarwal S; Greiner A J Am Chem Soc; 2008 Mar; 130(9):2710-1. PubMed ID: 18254626 [TBL] [Abstract][Full Text] [Related]
15. Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategies. Kocisko DA; Caughey B Methods Enzymol; 2006; 412():223-34. PubMed ID: 17046661 [TBL] [Abstract][Full Text] [Related]
16. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity. Vetrugno V; Cardinale A; Filesi I; Mattei S; Sy MS; Pocchiari M; Biocca S Biochem Biophys Res Commun; 2005 Dec; 338(4):1791-7. PubMed ID: 16288721 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436 [TBL] [Abstract][Full Text] [Related]
18. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy. Veith NM; Plattner H; Stuermer CA; Schulz-Schaeffer WJ; Bürkle A Eur J Cell Biol; 2009 Jan; 88(1):45-63. PubMed ID: 18834644 [TBL] [Abstract][Full Text] [Related]
19. Normal host prion protein necessary for scrapie-induced neurotoxicity. Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188 [TBL] [Abstract][Full Text] [Related]
20. pH-Induced aggregation of gold nanoparticles for photothermal cancer therapy. Nam J; Won N; Jin H; Chung H; Kim S J Am Chem Soc; 2009 Sep; 131(38):13639-45. PubMed ID: 19772360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]